Bayer Cropscience Share Price Slumps After Q3 Profit Decline
Bayer Cropscience's net profit declined 63.3% on the year to Rs 34.2 crore versus Rs 93.1 crore.
Bayer Cropscience Ltd.'s share price slumped on Wednesday as the company reported disappointing figures for third quarter. Net profit declined 63.3% on the year to Rs 34.2 crore versus Rs 93.1 crore.
The company reported a decline in bottom line despite reporting a rise in revenue growth during October–December.
Bayer Cropscience Q3 Results Highlights (YoY)
Revenue up 10.7% to Rs 1,056.90 crore versus Rs 954.90 crore (Bloomberg Estimate: Rs 1,037 crore).
Ebitda down 85% to Rs 19.70 crore versus Rs 127.90 crore (Bloomberg Estimate: Rs 123.90 crore).
Margin at 1.9% versus 13.4% (Bloomberg Estimate: 12%)
Net profit down 63% to Rs 34.20 crore versus Rs 93.10 crore (Bloomberg Estimate: Rs 94.2 crore).
Bayer Cropscience Share Price Today
Bayer Cropscience share price declined for four days in a row. It declined 8.06% to Rs 4,402.00 apiece, since July 31, 2023. The stock pared losses to trade 6.68% down at Rs 4,468.20 apiece as of 10:10 a.m., as compared to a 0.94% decline in the NSE Nifty 50.
The stock declined 25.01% in 12 months. Total traded volume so far in the day stood at 21 times its 30-day average. The relative strength index was at 24.32, which implied the stock was oversold.
Out of nine analysts tracking the company, three maintain a 'buy' rating, five recommend a 'hold' and one suggests 'sell', according to Bloomberg data. The average 12-month analysts' consensus price target implies an upside of 31.2%.
Corrects previous version by excluding the Agrochemical business' operating profit and updating Ebitda and margin figures for Q3 FY25.
